Institution
National Center for Geriatrics and Gerontology
Also known as: 国立研究開発法人国立長寿医療研究センター · NCGG
- 16running trials
- 7closed trials
- 5,585publications (OpenAlex)
Running trials
Recruiting
The Clinical Trial of Tamibarotene for Patients With HFpEF (RELIEF Trial)
Recruiting
A Study of LY4405094 in Healthy Participants and Participants With Alzheimer's Disease
Not yet recruiting
A Study of LY4560736 in Healthy Participants and Participants With Alzheimer's Disease (AD)
Recruiting
Recruiting
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
Recruiting
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
Recruiting
Efficacy and Safety With Early Treatment of Finerenone in Hospitalized Patients With Heart Failure
Recruiting
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
Recruiting
A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)
Active, not recruiting
A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)
Active, not recruiting
A Study of E2814 With Concurrent Lecanemab Treatment in Participants With Early Alzheimer's Disease
Active, not recruiting
A Pivotal Study of LIPUS-Brain in Patients With Early Alzheimer's Disease
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
Active, not recruiting
A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Alzheimer disease7 recruiting
- Heart failure2 recruiting
- Lewy body dementia1 recruiting
- Mild cognitive impairment1 recruiting
Closed trials
Completed
A Study of Mevidalen (LY3154207) in Participants With Alzheimer's Disease
Terminated
A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease
Completed
Completed
Completed
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)
Completed
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)
Completed
Registry name variants (6)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
National Center for Geriatrics and Gerontology
Ōbu, 474-8511
14 trials
National Center for Geriatrics and Gerontology
Obu-shi, Aichi-ken 474-8511
4 trials
National Center for Geriatrics and Gerontology_Comprehensive care
Obu-shi, Aichi, 474-8511
2 trials
National Center for Geriatrics and Gerontology
Obu-shi, Aichi-ken 474-8511
1 trial
National Center for Geriatrics and Gerontology
Obu-shi, Aichi-ken 474-8511
1 trial
National Center for Geriatrics and Gerontology (Site 9002)
Ōbu, Aichi-ken 474-8511
1 trial
NCT07033494A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
Contact: Study Coordinator
Conditions
Diseases this institution publishes on or runs trials for.
- Mild cognitive impairment30 works · 4 trials
Institution data: ROR 05h0rw812 (CC0-1.0)Updated 15 Nov 2026